Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety and effectiveness of an extended release form
of a medication called divalproex sodium (Depakote ER) for the treatment of people with
alcohol dependence who have mood and/or anxiety symptoms. This medication has helped reduce
symptoms of acute alcohol withdrawal as well as stabilize mood symptoms in bipolar disorder
and other mental health disorders. This study will test the hypothesis that divalproex sodium
will help reduce mood and anxiety symptoms during early abstinence from alcohol and in turn
reduce relapse and craving for alcohol.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Seattle Institute for Biomedical and Clinical Research